baber/WOPTO huggingface dataset:
Patent AT-E376408-T1 (AT)
Inventor: STEER GRAHAM EMERY
IPC: A61F5/445
Filed: 1999-12-16
Granted: 2007-11-15
Abstract: An ostomy pouch (10) is defined by a front wall (12) and a rear wall (14) having a stoma aperture (18). One or more rupturable capsules (24) are carried on a carrier or intervening wall (44) welded to the front and rear walls at a common weld seam (16). When desired, a capsule (24) can be ruptured by squeezing, the pouch wall together at that position, to dispense the contents (for example, a deodorising agent, a disinfectant or a preservative). In one form, the carrier does not cover the stoma aperture. In another form, the contents are dispensed on the side facing the front wall (12), and the curtain (44) shields the stoma aperture (18), to prevent the agent spurting out or contacting the stoma. In another form, one or more rupturable capsules may be arranged on the front wall (12) or on the rear wall (14). A plurality of the capsules (24) may contain different agents if desired. In another form, one or more self-dissolving capsules, for example, of gelatine, may be introduced into the pouch to dispense the agent in response to environmental conditions (for example, temperature/humidity) within the pouch.
Patent AT-E318796-T1 (AT)
Inventor: FROMMELT SIMON
IPC: E06B5/12
Filed: 1999-06-22
Granted: 2006-03-15
Abstract: Fire resistant glazing, having an edge spacer (3) of silicone rubber, is new. Fire resistant glazing comprises glass panes (1, 2) separated by a water-containing intermediate layer (4) and joined by a silicone rubber edge spacer (3) bonded to the panes, the joint between the spacer and the peripheral zones being sealed by adhesive (7). Preferred Features: The intermediate layer (4) comprises a hardened alkali metal polysilicate containing (by wt.) 30-55% silicon dioxide, NOTGREATER  16% alkali metal oxide and up to 60% water. A bead (6) of thermally foamable material is positioned between the spacer and the sealing adhesive, the material containing organic and/or inorganic substances (especially salts or oxides) which release gas (especially water vapor, ammonia, sulfur dioxide and/or boric acid) on heating.
Patent AT-E394064-T1 (AT)
Inventor: CANALE GIUSEPPE
IPC: F16B7/14
Filed: 1999-10-11
Granted: 2008-05-15
Abstract: A telescopic extension (1; 51) for an electric household appliance comprises an inner tube (2), an outer tube (3), a sleeve (4), at least one first constraining element (5; 6), a thrusting slider (7), resilient elements (24) and an actuating element (8); in the extension (1; 51) the sleeve (4) is arranged between the inner tube (2) and the outer tube (3) having a cross-section of substantially constant diameter, the sleeve (4) is provided with a longitudinal cavity (15) and a recess (19) formed on the bottom (18) of the cavity (15), the thrusting slider (7) is housed in the longitudinal cavity (15) and retained radially by the outer tube (3), the thrusting slider (7) is provided with at least one first slot (26) and the resilient means (24) are housed in the first slot (26) of the thrusting slider (7) and are engaged with a recess (19) of the sleeve (4). <IMAGE>
Patent AT-E245419-T1 (AT)
Inventor: SANKARANARAYANAN ALANGUDI
IPC: A61K31/4439
Filed: 1999-05-17
Granted: 2003-08-15
Abstract: The invention discloses a novel compound of the benzofuroxan series used for cardiovascular disorders represented by the general formula (I)and pharmaceutically acceptable salts thereofwherein:R is -O-(CH2)n-X-R';n=1 to 6;X is -NHC(O)-, or oxygen;R' is lower alkyl (C1-C8), aromatic, heteroaromatic, substituted or unsubstituted saturated heterocyclic ring with one or two hetero atoms such as nitrogen or oxygen wherein substitution is with lower alkyl;or R is selected fromwherein R'' is hydrogen, nitro, lower alkyl or-C(O)-R'''wherein R''' is hydrogen, lower alkyl or aryl.The invention also discloses process for the preparation of compounds of general formula I.The invention also discloses the use of the compounds of general formula I as defined above, as NO donors and/or in coronary heart diseases, and pharmaceutical compositions containing compounds of general formula I as active ingredients.The invention also discloses a method of treatment of mammal, including man, of coronary heart disease by administration of an effective amount of a compound of formula I as defined above.
Patent AT-E292278-T1 (AT)
Inventor: GROSSWIG STEPHAN
IPC: G01K11/12
Filed: 1999-05-07
Granted: 2005-04-15
Abstract: The invention relates to a method and a device for monitoring, also permanently and automatically, temperature distributions and/or temperature anomalies on the basis of distributed fiber-optic temperature sensing as well as to the use of such methods. According to the invention the detection of local temperature extremes, i.e. minimums or maximums, in view of the evaluation is performed by an evaluation without numeric derivations. With the device for monitoring ascending and supply pipes surrounded by an annular space it is possible to check the safety of pressurized installations, particularly in the field of low-pressure gas storage, in a cost-efficient manner. Moreover, the position of an underground watershed or respectively the direction and flow rate of the flows in flooded drift sections can be determined on the basis of fiber-optic temperature measurements. The defined arrangement of preferably vertical sensor cables inserted into the bores also makes it possible to examine the tightness of base sole and lateral walls in building excavations. Finally, the virtually horizontal, meander-shaped arrangement of fiber-optic cables situated in several levels makes it possible to evaluate and control the efficacy and homogeneity of leaching processes in leaching dumps and fills.
Patent AT-E254093-T1 (AT)
Inventor: BROWN HEATH
IPC: C04B28/02
Filed: 1999-07-30
Granted: 2003-11-15
Abstract: The present invention is directed to cementitious dry cast mixtures for forming cementitious articles, particularly a cementitious dry cast mixture containing a dispersant, wherein said dispersant is a derivatized polycarboxylate dispersant which is a polymer comprising units derived from at least a substituted carboxylic acid monomer or substituted ethylenically unsaturated monomer, and optionally including at least one of an unsaturated hydrocarbon, an N-polyoxyalkylene maleimide, and a condensation product of an unsubstituted carboxylic acid monomer and an alkoxypolyoxyalkylene primary amine substituted carboxylic acid monomer. The cementitious dry cast mixture has a reduced effective dose of dispersant; compacts and consolidates in response to vibration energy; reduces the cycle time in the production of articles manufactured from dry cast mixtures; provides for increased green strength, density, and early compressive strength; and improves the surface aesthetics of articles manufactured from dry cast mixtures. Additionally, a surface active agent/air entraining agent can be included in combination with the dispersant to provide for increased swipe effect.
Patent AT-E275431-T1 (AT)
Inventor: MIKKELSEN KAJ S
IPC: A63H33/08
Filed: 1999-10-13
Granted: 2004-09-15
Abstract: A toy building set comprising a plurality of building elements which each are provided with hinge parts, first and second types of hinge parts being shaped complementarily in such a manner that the hinge parts on two building elements may be interconnected releasably so that they form a hinge link between the building elements. The first type of hinge parts is provided with a toothing arranged at a specific distance from the common hinge axis, and the second type of hinge parts comprises a first group which is provided with a toothing arranged at the specific distance from the common hinge axis and a second group of hinge parts which is not provided with such a toothing, said toothings on the first type of hinge parts and on the first group of the second type of hinge parts being directed oppositely to each other in such a manner that they engage each other when the hinge parts are interconnected.
Patent AT-E246924-T1 (AT)
Inventor: DIB MICHEL
IPC: C07D457/02
Filed: 1999-11-22
Granted: 2003-08-15
Abstract: The invention concerns the use of nicergoline for preventing and/or treating motor neuron diseases.
Patent AT-E232632-T1 (AT)
Inventor: BREIVIK JARLE
IPC: G09B23/24
Filed: 1999-11-05
Granted: 2003-02-15
Abstract: The present invention provides a system of elements floating in a liquid, which can bind together by temperature dependent ferromagnetic forces, wherein the elements are physically designed to provide certain characteristics to the inter-elemental bindings, and that the magnetic forces are controlled by temperature. The magnetic interactions involve materials with Curie temperatures (Tc) corresponding to temperature changes in the environment of the elements, such that specific inter-elemental attractions cease when the temperature is elevated to specific levels. The invention further comprises use of the system to simulate chemical interactions, and catalysis, wherein the bindings are manipulated by varying temperature and turbulence, and use of the system as an educational tool, an interactive game, a decoration and a tool for scientific purposes.
Patent AT-E268807-T1 (AT)
Inventor: NALESNIK THEODORE E
IPC: C10M135/16
Filed: 1999-09-27
Granted: 2004-06-15
Abstract: Disclosed herein is a composition comprising: (A) a lubricant, and (B) at least one cyclic thiourea selected from the group consisting of: wherein R1 and R2 are independently selected from the group consisting of alkyl, functionalized alkyl, and hydrogen.
Patent DE-01270376-T1 (DE)
Inventor: VINCENT NATHALIE
IPC: B01D65/02
Filed: 2001-12-04
Abstract: The invention concerns a method for avoiding irreversible membrane clogging while maximising productivity, whatever the quality of the fluid at the installation intake. It consists in automatically controlling the installation operating parameters by performances induced by the quality of the fluid to be treated, based on predictions concerning the evolution of the membrane clogging carried out by modelling with a neuron network so as to simulate the long term operating conditions of the membrane filtering installation, the model enabling, on the basis of the quality of the in-flowing fluid and on the state of the membranes during a given cycle, to calculate the evolution of the clogging state of said membranes on a time basis, on a specific horizon, said calculation being performed for a simulated in-flowing quality, constant or variable, on said horizon (H) and to control and adjust the installation operating parameters.
Patent DE-04821913-T1 (DE)
Title: Steuersystem für fahrzeuge
Inventor: BUILTA E
IPC: G05D1/02
Filed: 2004-03-25
Abstract: System
zur Steuerung des Flugs eines Flugzeugs, umfassend:  ein an
dem Flugzeug angeordnetes Sensorsystem zur Erfassung einer Position
des Flugzeugs und einer Trägheitsbewegung
des Flugzeugs, wobei das Sensorsystem dazu eingerichtet ist, erfasste
Daten, die die Position und Trägheitsbewegung
des Flugzeugs darstellen, zu übermitteln;  einen
Empfänger,
der an dem Flugzeug angeordnet und dazu eingerichtet ist, empfangene
Referenzdaten, die eine Position und Bewegung eines Referenzfahrzeugs übermitteln,
zu empfangen;  Befehlsdaten, die eine ausgewählte Geschwindigkeit des Flugzeugs
in Bezug zu dem Referenzfahrzeug darstellen; und  ein an dem
Flugzeug angeordnetes Steuersystem zur Berechnung einer errechneten
Geschwindigkeit des Flugzeugs in Bezug zu dem Referenzfahrzeug,
unter Verwendung der erfassten Daten und der Referenzdaten und zur Steuerung
von Flugsteuerungsvorrichtungen an dem Flugzeug, sodass das Flugzeug
eine ausgewählte
Geschwindigkeit in Bezug zu dem Referenzfahrzeug entsprechend den
Befehlsdaten annimmt und beibehält.
Patent DE-15186610-T1 (DE)
Title: Reifendruckverringerungserkennungsvorrichtung,- Verfahren und -Programm
Inventor: YANASE MINAO
IPC: B60C23/06
Filed: 2015-09-24
Abstract: Reifendruckabnahmeerfassungsvorrichtung mit: einer Rotationsgeschwindigkeitsinformationserfassungseinheit zum Erfassen einer Rotationsgeschwindigkeitsinformation von Rädern eines Fahrzeugs; einer Resonanzfrequenzschätzeinheit zum Schätzen einer Torsionsresonanzfrequenz der Rotationsgeschwindigkeitsinformation in einer Zeitreihe aus der Rotationsgeschwindigkeitsinformation, die durch die Rotationsgeschwindigkeitsinformationserfassungseinheit erhalten wird; und einer Beurteilungseinheit zum Beurteilen einer Abnahme des Drucks der Reifen, die auf den Rädern installiert sind, basierend auf der geschätzten Torsionsresonanzfrequenz, wobei die Resonanzfrequenzschätzeinheit eine Rauschentfernungseinheit zum Entfernen eines Rauschens, das einem Radgeschwindigkeitssignal, das als die Rotationsgeschwindigkeitsinformation für jedes der Räder dient, überlagert ist, unter Verwendung einer aktiven Rauschsteuerungstechnologie enthält.
Patent DE-78191-T1 (DE)
IPC: A61K31/785
Filed: 1982-10-14
Abstract: There is disclosed the use of a collagen inhibiting composition including in polymeric form select analogs of proline and processes for the manufacture and use of such a collagen-inhibiting composition to reduce scar tissue formation.
Patent DE-94267-T1 (DE)
IPC: A63B69/40
Filed: 1983-04-13
Abstract: Balls such as table tennis balls or tennis balls are continuously fed to two pairs of adjacent flanged rollers of a ball-throwing head by a blower and two transfer ducts. Balls hit by the player are collected by a net and a trough, then fed back to the head. The rollers have separately variable speeds of rotation, a gap being provided between each pair of rollers and adapted to the diameter of the balls. The balls are directed alternately into each transfer duct, the opening of which is located opposite to each gap.
Patent DE-152712-T1 (DE)
IPC: B65G47/08
Filed: 1984-12-26
Abstract: 1. A process for forming a load by stacking bags or boxes in horizontal layers, during the course of which process the bags are transported from a single bag supplying apparatus to a stacking table (21), the process comprising the following steps : a) at the outlet of the supply apparatus the bags are arranged in two lines (10, 11) along two sides of the stacking table ; b) these two lines are transferred onto the stacking table to form a layer ; c) the stacking table is lowered by a height corresponding to that of the said layer, then a further layer is formed ; and d) when the desired stack has been formed, it is ejected from the stacking table, the process being characterised in that the bags are arranged along two perpendicular sides of the stacking table without changing their orientation, and, a first line (10) being formed along a first side of the stacking table, a second line (11) is formed along the second side of the stacking table at the same time as the first line (10) is being transferred onto the stacking table, then the stacking table is rotated through 90 degrees and a fresh line (10) is formed along the first side of the stacking table at the same time as the second line (11) is being transferred onto the stacking table.
Patent DE-131052-T1 (DE)
IPC: C12Q1/68
Filed: 1984-01-09
Abstract: A method for detecting rRNA-specific nucleic acids, tRNA-specific nucleic acids, psrRNA-specific nucleic or pstRNA-nucleic acids of a non-viral organism or group of non-viral organisms in the sample is described.
Patent DE-717866-T1 (DE)
Inventor: WRIGHT MICHAEL
IPC: G05B19/4093
Filed: 1994-09-07
Abstract: A CNC machine tool control system that includes a controllable, movable tool for shaping a workpiece, a mechanism for receiving control instructions describing shaping functions to be performed on the workpiece, a processing unit and memory. The control systems includes objects defined according to an object oriented design. One type of object is a model of a shaping process to be performed on a workpiece, including informational parameters regarding the physical dimensions of the shape resulting from the process. The process objects communicates through an object oriented messaging system to machine objects, which represent physical devices present on the CNC machine on which the control system operates. The system also includes object oriented motion control and exception handler objects, each of which may communication with other object via object oriented messages. The control system permits easy modifications to the control system by persons with limited knowledge about the entire control system, and is readily adaptable to advances in new CNC machine tools.
Patent DE-678843-T1 (DE)
Inventor: KIKINIS DAN
IPC: G09G5/18
Filed: 1993-11-29
Abstract: A computer system (233) comprising a central processing unit (CPU) (115;215), input apparatus (245, 251, 257), a video monitor (347; 447; 547), and comprising timer means (259) for monitoring activity of said input apparatus (245, 251, 257); signalling means (217) for signalling the video monitor to assume an alternative power state in response to output from the timer means; and power management means (339) for removing power from power using circuits in the monitor (347; 447; 547); characterised in that the video monitor (347; 447; 547) is capable of entering any one of two or more reduced power states in response to a specific command sent by the signalling means, in that specific commands are associated in the video monitor with specific reduced power states, and in that the video monitor enters an appropriate state according to the command sent by the signalling means.
Patent ES-2851123-T1 (ES)
Title: Receptores quiméricos de antígeno específicos de glipicano-3 para inmunoterapia adoptiva
Inventor: HECZEY ANDRAS
IPC: C12N15/09
Filed: 2015-09-25
Abstract: Linfocitos T que expresan un receptor quimérico de antígeno (CAR) que se dirige a glipicano-3 (GPC3) para su uso en un método de tratamiento de una enfermedad asociada con la proliferación y/o actividad de células GPC3 positivas en un individuo, comprendiendo el método la etapa de poner en contacto las células con una cantidad terapéuticamente eficaz de los linfocitos T y comprendiendo el CAR (i) un anticuerpo scFv distinto de 3E11, 2G9, 4G5, 3D8 o 2E10 y (ii) un dominio coestimulante de CD28, en donde: (a) los linfocitos T albergan un polinucleótido que codifica el CAR y comprende la SEQ ID NO: 19, SEQ ID NO: 33, SEQ ID NO: 12 o SEQ ID NO: 29, o una combinación de las mismas; y/o (b) la CAR comprende la secuencia de aminoácidos de la SEQ ID NO: 18, SEQ ID, SEQ ID NO: 32, SEQ ID NO: 10 o SEQ ID NO: 28, o una combinación de las mismas; en donde la enfermedad es cáncer o síndrome de Simpson-Golabi-Behmel.
Patent ES-2113843-T1 (ES)
Title: Procedimiento de fabricacion de una matriz de prensado principalmente de discos opticos y matriz asi obtenida.
Inventor: ANDRE PASCAL
IPC: G11B7/26
Filed: 1997-06-27
Abstract: LA PRESENTE INVENCION SE REFIERE A UN PROCEDIMIENTO DE FABRICACION DE UNA MATRIZ DE PRENSADO, PARTICULARMENTE DE DISCOS OPTICOS ASI COMO LA MATRIZ DE PRENSADO ASI OBTENIDA. EL PROCEDIMIENTO DE FABRICACION DE UNA MATRIZ DE PRENSADO DE LA INVENCION SE CARACTERIZA PORQUE COMPRENDE LAS ETAPAS DE: DEPOSITO SOBRE UN SUSTRATO DE UNA CAPA DE RESINA FOTOSENSIBLE, GRABACION DE LA INFORMACION A DUPLICAR, EN FORMA DE IMAGEN LATENTE, EN LA CAPA DE RESINA FOTOSENSIBLE; ELIMINACION DE LAS ZONAS DE RESINA INSOLADAS DE LA CAPA DE RESINA FOTOSENSIBLE; CRECIMIENTO DE MICRORRELIEVES EN LAS ZONAS DONDE LA RESINA FOTOSENSIBLE HA SIDO ELIMINADA; Y ELIMINACION DE LA RESINA RESIDUAL. LA INVENCION PERMITE OBTENER MATRICES DE PRENSADO UTILIZABLES PARA EL PRENSADO PARTICULARMENTE DE DISCOS OPTICOS.
Patent CY-1108095-T1 (CY)
Title: Αντικαρκινικα αναλογα της ετ-743
Inventor: MANZANARES IGNACIO
IPC: C07D471/18
Filed: 2007-10-29
Abstract: Oι αντικαρκινικές ενώσεις έχουν τη δομή του πενταμελούς συγχωνευμένου δακτυλίου εκτεινασκιδίνης του τύπου (ΧΙV). Οι παρούσες ενώσεις στερούνται μιας 1,4-γεφυροποιού ομάδας σαν αυτή που βρίσκεται στις εκτεϊνασκιδίνες. ΄Εχουν στη C-1 θέση έναν υποκαταστάτη επιλεγμένο από μια κατ΄ επιλογή προστατευμένη ή παραγωγοποιημένη αμινομεθυλενική ομάδα ή μια κατ’ επιλογή προστατευμένη ή παραγωγοποιημένη υδροξυμεθυκενική ομάδα.
Patent CY-1108382-T1 (CY)
Inventor: ESIKOVA IRINA
IPC: A61K39/385
Filed: 2008-09-30
Abstract: The present invention is directed to compositions and methods for the preparation of biological molecules, in particular MenC-CRM 197. Biological molecules dissolved in dissolution buffers comprising at least one amorphous excipient and an amorphous buffer exhibit reduced aggregation and proteolytic breakdown.
Patent CY-1111518-T1 (CY)
Inventor: DAVIES JULIAN
IPC: G01N33/68
Filed: 2011-05-13
Abstract: TGF-beta 1 binding compositions and reagents related thereto are provided. Methods of using such compositions for therapeutic purpose are also provided.
Patent CY-1112128-T1 (CY)
Title: Χρηση il-18bp ισομορφων για την αντιμετωπιση και/ή προληψη νευρολογικων φλεγμονωδων νοσων
Inventor: SAGOT YVES
IPC: A61P25/00
Filed: 2011-11-30
Abstract: Η εφεύρεση σχετίζεται με τη χρήση μιας IL18-BP ισομορφής η οποία δεν δεσμεύεται σε IL18, ή ενός αγωνιστή αυτής, για αντιμετώπιση ή πρόληψη μιας νευρολογικής και/ή φλεγμονώδους νόσου. Προτιμητέες ισομορφές για χρήση στο πλαίσιο της παρούσας εφεύρεσης περιλαμβάνουν IL-18BPb και IL-18BPd.
Patent CY-1114776-T1 (CY)
Title: Συνθεσεις πολυαιθυλενιογλυκολης για τον ελεγχο των υποτροπων του επιχειλιου ερπητα, του ερπητα των γεννητικων οργανων και του ερπητα ζωστηρα
Inventor: VITINS PETER
IPC: A61K31/765
Filed: 2014-01-23
Abstract: Η παρούσα εφεύρεση αναφέρεται γενικά στο πεδίο της θεραπείας και ειδικότερα στο πεδίο της θεραπείας του απλού έρπητα και του έρπητα ζωστήρα και πιο συγκεκριμένα, σε μεθόδους μειώσεως του ποσοστού των υποτροπών, καθυστερήσεως των υποτροπών και/ή προλήψεως των υποτροπών του επιχείλιου έρπητα ("σχηματισμός ομάδας φυσαλίδων από έρπητα" επί των χειλέων), του έρπητα των γεννητικών οργάνων (γεννητικός έρπητας) και του έρπητα ζωστήρα (shingles, zona (Σ.τ.Μ.: στα ελληνικά οι προαναφερθέντες όροι αποδίδονται ως έρπης ζωστήρας)) δια τοπικής χορηγήσεως πολυαιθυλενιογλυκόλης (PEG) ή μίας συνθέσεως που περιλαμβάνει PEG.
Patent CY-1115917-T1 (CY)
Inventor: ARUL RAMAKRISHNAN
IPC: A61K31/4365
Filed: 2015-01-12
Abstract: The present invention relates to novel crystalline forms of the platelet aggregation inhibitor (+)-(S)-methyl-2-(2-chlorophenyl)-(6,7-dihydro-4H-thieno[3,2-c]pyrid-5-yl)acetate, clopidogrel (1), in the form of hydrogen bromide salts, identified as polymorph forms 1, 2 and 3. The present invention further relates to processes for preparing such forms, pharmaceutical compositions comprising such forms, and uses for such forms and compositions.  The pharmaceutical compositions may be used, in particular, for inhibiting platelet aggregation or for treating, preventing or managing thrombosis, atherothrombosis, an atherothrombotic event, ischaemic stroke, myocardial infarction, non-Q-wave myocardial infarction, atherosclerosis, peripheral arterial disease, or unstable angina. The present invention also relates to methods of treating said disorders.
Patent CY-1119153-T1 (CY)
Inventor: SHIMIZU TOSHIHIRO
IPC: A61K31/44
Filed: 2016-01-28
Abstract: An orally disintegrable tablet, of the present invention, which comprises (i) fine granules having an average particle diameter of 400 mu m or less, which fine granules comprise a composition coated by an enteric coating layer, said composition having 10 weight % or more of an acid-labile physiologically active substance and (ii) an additive, has superior disintegrability or dissolution in the oral cavity so that it can be used for treatment or prevention of various diseases, as an orally disintegrable tablet capable of being administered to the aged or children and easily administered without water. Also, because the tablet of the present invention contains fine granules having the average particle diameter such that it will not impart roughness in mouth, it can be administered easily without discomfort at the administration.